MedPath

Optimal Length for Nasal Mid-turbinate and Nasopharyngeal Swabs

Not Applicable
Completed
Conditions
Covid19
Registration Number
NCT04840082
Lead Sponsor
Rigshospitalet, Denmark
Brief Summary

This study aim to explore the optimal swap insertion length for mid-turbinate and nasopharyngeal samples. Our clinical trial took place at a Covid-19 test center in Copenhagen. Participants consisted of voluntary citizens who were at the test center for a nasopharyngeal antigen quicktest. An endoscopic examination was performed simultaneous with the swap to measure the length from the vestibulum nasi to the posterior wall of the nasopharynx and the mid-turbinate.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
109
Inclusion Criteria
  • Referred for COVID-19 testing
Exclusion Criteria
  • Nose patology

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Length from the vestibulum nasi to the posterior wall of the nasopharynx.From inclusion at the testcenter until the COVID-19 testing was completed.

Endoscopic measurement of the length from the vestibulum nasi to the posterior wall of the nasopharynx.

Length from the vestibulum nasi to the mid-turbinate.From inclusion at the testcenter until the endoscopic examination was completed

Endoscopic measurement of the length from the vestibulum nasi to the mid-turbinate.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Rigshospitalet

🇩🇰

Copenhagen, Copenhagen East, Denmark

Rigshospitalet
🇩🇰Copenhagen, Copenhagen East, Denmark

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.